ISG15 promotes PARP inhibitor resistance in BRCA1-deficient cells by facilitating DNA replication and repair
Despite promising initial responses, BRCA1/2-mutated cancers treated with PARP inhibitors (PARPi) often develop resistance.
Despite promising initial responses, BRCA1/2-mutated cancers treated with PARP inhibitors (PARPi) often develop resistance.